Prognostic Value of GIMAP4 and Its Role in Promoting Immune Cell Infiltration into Tumor Microenvironment of Lung Adenocarcinoma

Figure 3

GIMAP4 expression in NSCLC subtypes. (a) Expression of GIMAP4 in lung adenocarcinoma (LUAD) and in lung squamous cell carcinoma (LUSC). (b) Expression of GIMAP4 in lung tissue. (c) Verification of GIMAP4 expression in GEO database. (d) Association between GIMAP4 and immune subtypes of lung cancers. C1: wound healing; C2: IFN-gamma dominant; C3: inflammatory; C4: lymphocyte depleted; C5: immunologically quiet; C6: TGF-b dominant.

(a)

(b)

(c)

(d)